Sath Shukla

Affiliations

  • Ceo And President at Spero Therapeutics Inc. (SPRO), 2024-02-06
  • Evp, Chief Financial Officer at Ziopharm Oncology Inc (ZIOP), 2020-01-31
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
SPRO $1.45 45,093 1,176,007 2024-02-05 Filing
SPRO $1.37 30,901 1,221,100 2024-02-02 Filing
SPRO $1.30 4,163 572,500 2023-08-29 Filing
SPRO $1.26 1,854 576,663 2023-08-28 Filing
SPRO $1.83 9,504 Officer 312,517 2023-02-02 Filing